Literature DB >> 10496149

Pineal indoleamines and vitamin E reduce nitric oxide-induced lipid peroxidation in rat retinal homogenates.

A W Siu1, R J Reiter, C H To.   

Abstract

Oxidative damage to retinal cell membranes can lead to sight-threatening ocular diseases. Pineal indoleamines are naturally located and synthesized in the retina, and they possibly protect the retina from oxidative cell damage. In this study, we compared the efficacy of three different pineal indoleamines (melatonin, N-acetylserotonin, and pinoline) with vitamin E, a well-known antioxidant, against nitric oxide (NO)-induced lipid peroxidation (LPO) in rat retinal homogenates. The possible synergistic effect of these agents was also studied. Retinal homogenates were incubated with sodium nitroprusside, which releases NO*. The LPO product, malondialdehyde (MDA), provided an index of cell damage. The results show that vitamin E and indoleamines significantly reduced MDA levels in a dose-dependent manner. When vitamin E was combined with the indoleamines, the protection was synergistically enhanced. In summary, under conditions where cellular homogenates are used (a) vitamin E and the three pineal indoleamines protected the retinal cells from NO-induced LPO damage; (b) the efficacies of each of these compounds had the following relationships: vitamin E > N-acetylserotonin > pinoline > melatonin; (c) vitamin E acted synergistically with indoleamines in combating oxidative retinal damage. Whether these same associations would exist in vivo after treatment with these compounds is unknown. The pharmacological potential of indoleamines, possibly in combination with vitamin E, in preventing retinal pathogenesis deserves further investigation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10496149     DOI: 10.1111/j.1600-079x.1999.tb00606.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  23 in total

1.  Melatonin MT-1-receptor immunoreactivity in the human eye.

Authors:  P Meyer; M Pache; K U Loeffler; L Brydon; R Jockers; J Flammer; A Wirz-Justice; E Savaskan
Journal:  Br J Ophthalmol       Date:  2002-09       Impact factor: 4.638

2.  Protective effects of various antioxidants during ischemia-reperfusion in the rat retina.

Authors:  Nihat Dilsiz; Ayse Sahaboglu; M Zulfu Yildiz; Andreas Reichenbach
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-05       Impact factor: 3.117

Review 3.  Melatonin and nitric oxide.

Authors:  S Aydogan; M Betul Yerer; A Goktas
Journal:  J Endocrinol Invest       Date:  2006-03       Impact factor: 4.256

Review 4.  Extrapineal melatonin: sources, regulation, and potential functions.

Authors:  Darío Acuña-Castroviejo; Germaine Escames; Carmen Venegas; María E Díaz-Casado; Elena Lima-Cabello; Luis C López; Sergio Rosales-Corral; Dun-Xian Tan; Russel J Reiter
Journal:  Cell Mol Life Sci       Date:  2014-02-20       Impact factor: 9.261

5.  Distribution of oxidation enzyme eNOS and myeloperoxidase in primary open angle glaucoma.

Authors:  Hui-Ju Lin; Chang-Hai Tsai; Fuu-Jen Tsai; Wei-Cheng Chen; Shih-Wei Tsai; Seng-Sheen Fan
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

6.  Effects of melatonin on the nitric oxide treated retina.

Authors:  A W Siu; G G Ortiz; G Benitez-King; C H To; R J Reiter
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

7.  Melatonin and structurally-related compounds protect synaptosomal membranes from free radical damage.

Authors:  Sergio Millán-Plano; Eduardo Piedrafita; Francisco J Miana-Mena; Lorena Fuentes-Broto; Enrique Martínez-Ballarín; Laura López-Pingarrón; María A Sáenz; Joaquín J García
Journal:  Int J Mol Sci       Date:  2010-01-21       Impact factor: 5.923

Review 8.  Melatonin: an underappreciated player in retinal physiology and pathophysiology.

Authors:  Gianluca Tosini; Kenkichi Baba; Christopher K Hwang; P Michael Iuvone
Journal:  Exp Eye Res       Date:  2012-08-31       Impact factor: 3.467

9.  Melatonin modulates visual function and cell viability in the mouse retina via the MT1 melatonin receptor.

Authors:  Kenkichi Baba; Nikita Pozdeyev; Francesca Mazzoni; Susana Contreras-Alcantara; Cuimei Liu; Manami Kasamatsu; Theresa Martinez-Merlos; Enrica Strettoi; P Michael Iuvone; Gianluca Tosini
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-14       Impact factor: 11.205

10.  The melatonin-producing system is fully functional in retinal pigment epithelium (ARPE-19).

Authors:  Michał A Zmijewski; Trevor W Sweatman; Andrzej T Slominski
Journal:  Mol Cell Endocrinol       Date:  2009-05-03       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.